$ARVN
Arvinas Inc Stock $arvn

$arvn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165575924000018 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$25.30M	-$43.10M	$78.50M
YoY Change	-22.15%	-194.52%	-40.26%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$24.30M	$27.00M	$100.3M
YoY Change	-2.41%	78.81%	26.01%
% of Gross Profit
Research & Development	$84.30M	$95.20M	$379.7M
YoY Change	-11.54%	-3.15%	20.54%
% of Gross Profit
Depreciation & Amortization	$1.200M	$1.200M	$4.800M
YoY Change	0.0%	-29.41%	-23.81%
% of Gross Profit
Operating Expenses	$108.6M	$122.2M	$480.0M
YoY Change	-9.65%	7.76%	21.64%
Operating Profit	-$83.30M		-$401.5M
YoY Change	-5.02%		52.55%
Interest Expense	$0.00	$12.10M	$0.00
YoY Change		112.28%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$14.00M	-$1.200M	$37.60M
YoY Change	115.38%	-300.0%	208.2%
Pretax Income	-$69.30M	-$153.2M	-$363.9M
YoY Change	-14.66%	149.11%	44.98%
Income Tax	$100.0K	$1.600M	$900.0K
% Of Pretax Income
Net Earnings	-$69.40M	-$154.8M	-$367.3M
YoY Change	-15.26%	86.73%	30.02%
Net Earnings / Revenue	-274.31%		-467.9%
Basic Earnings Per Share	-$0.97		-$6.62
Diluted Earnings Per Share	-$0.97	-$2.53	-$6.62
COMMON SHARES
Basic Shares Outstanding	68.08M shares	55.03M shares	55.50M shares
Diluted Shares Outstanding	71.70M shares		55.50M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.169B	$1.261B	$1.261B
YoY Change	4.08%	4.62%	4.62%
Cash & Equivalents	$88.00M	$311.7M	$311.7M
Short-Term Investments	$1.081B	$949.3M	$949.3M
Other Short-Term Assets	$13.90M	$12.00M	$12.00M
YoY Change	-30.5%	-55.39%	-55.39%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00	$0.00
Other Receivables	$7.100M	$7.200M	$7.200M
Total Short-Term Assets	$1.190B	$1.280B	$1.280B
YoY Change	3.67%	3.23%	3.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.40M	$11.50M	$14.00M
YoY Change	-22.39%	-14.18%	-21.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change
Other Assets	$9.900M	$10.40M	$10.40M
YoY Change	-3.88%	-3.7%	-3.7%
Total Long-Term Assets	$22.30M	$24.40M	$24.40M
YoY Change	-19.2%	-14.69%	-14.69%
TOTAL ASSETS
Total Short-Term Assets	$1.190B	$1.280B	$1.280B
Total Long-Term Assets	$22.30M	$24.40M	$24.40M
Total Assets	$1.213B	$1.305B	$1.305B
YoY Change	3.13%	2.82%	2.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.80M	$17.80M	$92.20M
YoY Change	44.72%	212.28%	1517.54%
Accrued Expenses	$56.70M	$1.900M	$1.900M
YoY Change	24.62%	-96.86%	-96.86%
Deferred Revenue	$162.9M	$163.0M
YoY Change	-24.2%	-25.43%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$200.0K
YoY Change	100.0%
Total Short-Term Liabilities	$240.8M	$257.1M	$257.1M
YoY Change	-14.88%	-12.88%	-12.88%
LONG-TERM LIABILITIES
Long-Term Debt	$700.0K	$800.0K	$800.0K
YoY Change	-22.22%	-20.0%	-20.0%
Other Long-Term Liabilities	$361.4M	$386.7M	$386.7M
YoY Change	-5.14%	-5.17%	-5.17%
Total Long-Term Liabilities	$700.0K	$800.0K	$387.5M
YoY Change	-22.22%	-20.0%	-5.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$240.8M	$257.1M	$257.1M
Total Long-Term Liabilities	$700.0K	$800.0K	$387.5M
Total Liabilities	$602.9M	$644.6M	$644.6M
YoY Change	-9.31%	-8.42%	-8.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.402B	-$1.333B
YoY Change	33.88%	38.05%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$609.7M	$660.0M	$660.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.213B	$1.305B	$1.305B
YoY Change	3.13%	2.82%	2.82%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$69.40M	-$154.8M	-$367.3M
YoY Change	-15.26%	86.73%	30.02%
Depreciation, Depletion And Amortization	$1.200M	$1.200M	$4.800M
YoY Change	0.0%	-29.41%	-23.81%
Cash From Operating Activities	-$97.50M	-$83.10M	-$347.8M
YoY Change	6.91%	16.71%	27.17%
INVESTING ACTIVITIES
Capital Expenditures	$100.0K	$100.0K	$2.900M
YoY Change	-90.91%	-90.91%	-57.35%
Acquisitions
YoY Change
Other Investing Activities	-$127.7M	-$53.60M	$206.4M
YoY Change	-191.41%	-361.46%	-17.31%
Cash From Investing Activities	-$127.8M	-$53.70M	$203.5M
YoY Change	-192.21%	-376.8%	-16.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$200.0K
YoY Change
Cash From Financing Activities	$1.600M	334.8M	$374.7M
YoY Change	6.67%	66860.0%	7872.34%
NET CHANGE
Cash From Operating Activities	-$97.50M	-83.10M	-$347.8M
Cash From Investing Activities	-$127.8M	-53.70M	$203.5M
Cash From Financing Activities	$1.600M	334.8M	$374.7M
Net Change In Cash	-$223.7M	198.0M	$230.4M
YoY Change	-557.46%	-485.96%	-986.15%
FREE CASH FLOW
Cash From Operating Activities	-$97.50M	-$83.10M	-$347.8M
Capital Expenditures	$100.0K	$100.0K	$2.900M
Free Cash Flow	-$97.60M	-$83.20M	-$350.7M
YoY Change	5.74%	15.08%	25.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-367300000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	16100000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-14500000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-351200000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-297000000.0	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-196200000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	642200000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	57100000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	781700000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	75500000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4800000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	564900000	usd
CY2021	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	7200000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6800000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4700000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	203500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	242800000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588400000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	317200000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86800000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001655759
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38672
CY2023	dei	Entity Registrant Name EntityRegistrantName	ARVINAS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2566120
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Science Park
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	395 Winchester Ave
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New Haven
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06511
CY2023	dei	City Area Code CityAreaCode	203
CY2023	dei	Local Phone Number LocalPhoneNumber	535-1456
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	ARVN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1293400000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68083928	shares
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	311700000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81300000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5500000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5500000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	949300000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1124000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1000000.0	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7200000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7000000.0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6500000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21400000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1280200000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1240200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11500000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2500000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4400000	usd
CY2023Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	10400000	usd
CY2022Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	10800000	usd
CY2023Q4	us-gaap	Assets Assets	1304600000	usd
CY2022Q4	us-gaap	Assets Assets	1268800000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	92200000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	74700000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	163000000.0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	218600000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1900000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1800000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	257100000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	295100000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	386200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	405100000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	800000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	500000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2700000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	644600000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	703900000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68000000.0	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68000000.0	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53200000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53200000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1332700000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-965400000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1995700000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1549400000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3100000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19200000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	660000000.0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	564900000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1304600000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1268800000	usd
CY2023	us-gaap	Revenues Revenues	78500000	usd
CY2022	us-gaap	Revenues Revenues	131400000	usd
CY2021	us-gaap	Revenues Revenues	53600000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	379700000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	315000000.0	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	180400000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100300000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79600000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61600000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	480000000.0	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	394600000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	242000000.0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-401500000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-263200000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-188400000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1200000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2500000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	38800000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000000.0	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1800000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	37600000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12200000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4300000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-363900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-251000000.0	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-184100000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20900000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10600000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6900000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191000000.0	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.31
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55500000	shares
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18700000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4600000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	259900000	usd
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-5200000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-282500000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-14600000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	71600000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-367300000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4500000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	17000000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	370200000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	16100000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	660000000.0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-282500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191000000.0	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4800000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6300000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4800000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	16600000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-5700000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-9400000	usd
CY2023	arvn	Debt Instrument Loan Forgiveness DebtInstrumentLoanForgiveness	0	usd
CY2022	arvn	Debt Instrument Loan Forgiveness DebtInstrumentLoanForgiveness	0	usd
CY2021	arvn	Debt Instrument Loan Forgiveness DebtInstrumentLoanForgiveness	1000000.0	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-900000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-400000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-200000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1900000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1900000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1200000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1300000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1800000	usd
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	400000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	71600000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	75500000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	57100000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1000000.0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14000000.0	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14000000.0	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	200000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3700000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3300000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-14100000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1800000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13600000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	12900000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	17300000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20200000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	27900000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2000000.0	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1900000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1300000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-74600000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-116800000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	695500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-347800000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-273500000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	559400000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	956300000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	886400000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1744600000	usd
CY2023	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	1103900000	usd
CY2022	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	1076900000	usd
CY2021	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	428500000	usd
CY2023	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	58800000	usd
CY2022	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	59100000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2900000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1313600000	usd
CY2023	arvn	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	387200000	usd
CY2022	arvn	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	0	usd
CY2021	arvn	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	264600000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	17000000.0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4600000	usd
CY2023	arvn	Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares	4500000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	278600000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26000000.0	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-475600000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112800000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	100000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	500000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	100000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11100000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11100000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	arvn	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	4	subsidiary
CY2023Q4	arvn	Cash Cash Equivalents Restricted Cash And Marketable Securities CashCashEquivalentsRestrictedCashAndMarketableSecurities	1300000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	311700000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81300000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108300000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5500000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5500000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	317200000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86800000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112800000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div>The Company maintains its cash in financial institution accounts that may at times exceed federally insured limits. The cash balances in the financial institutions are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. Cash may also be maintained at commercial institutions that are not insured by the FDIC.
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	operating_segment
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5900000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4100000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3100000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2200000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1000000.0	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15000000.0	usd
CY2023	arvn	Accounts Receivable After Allowance For Credit Loss Current Additions AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions	21700000	usd
CY2022	arvn	Accounts Receivable After Allowance For Credit Loss Current Additions AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions	6400000	usd
CY2023	arvn	Accounts Receivable After Allowance For Credit Loss Current Payments Received AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived	22700000	usd
CY2022	arvn	Accounts Receivable After Allowance For Credit Loss Current Payments Received AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived	20400000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1000000.0	usd
CY2022Q4	arvn	Accounts Payable Contract Balances Current AccountsPayableContractBalancesCurrent	5000000.0	usd
CY2021Q4	arvn	Accounts Payable Contract Balances Current AccountsPayableContractBalancesCurrent	0	usd
CY2023	arvn	Accounts Payable Contract Balances Current Additions AccountsPayableContractBalancesCurrentAdditions	44100000	usd
CY2022	arvn	Accounts Payable Contract Balances Current Additions AccountsPayableContractBalancesCurrentAdditions	5000000.0	usd
CY2023	arvn	Accounts Payable Contract Balances Current Payments AccountsPayableContractBalancesCurrentPayments	36000000.0	usd
CY2022	arvn	Accounts Payable Contract Balances Current Payments AccountsPayableContractBalancesCurrentPayments	0	usd
CY2023Q4	arvn	Accounts Payable Contract Balances Current AccountsPayableContractBalancesCurrent	13100000	usd
CY2022Q4	arvn	Accounts Payable Contract Balances Current AccountsPayableContractBalancesCurrent	5000000.0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	10700000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	12500000	usd
CY2023	arvn	Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements	0	usd
CY2022	arvn	Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements	0	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1300000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1800000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	9400000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	10700000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	623700000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	740500000	usd
CY2023	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	1500000	usd
CY2022	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	4000000.0	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-76000000.0	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-120000000.0	usd
CY2023	arvn	Contract With Customer Liability Revenue Recognized Not Included In Previous Balance ContractWithCustomerLiabilityRevenueRecognizedNotIncludedInPreviousBalance	0	usd
CY2022	arvn	Contract With Customer Liability Revenue Recognized Not Included In Previous Balance ContractWithCustomerLiabilityRevenueRecognizedNotIncludedInPreviousBalance	-800000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	549200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	623700000	usd
CY2022	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	700000	usd
CY2021	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-800000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	549200000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	163000000.0	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	153400000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	105000000.0	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	57600000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	59800000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10400000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	549200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30000000.0	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21100000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16600000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11500000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13400000	usd
CY2023	us-gaap	Depreciation Depreciation	4800000	usd
CY2022	us-gaap	Depreciation Depreciation	6300000	usd
CY2021	us-gaap	Depreciation Depreciation	4800000	usd
CY2021Q2	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	160000	sqft
CY2021Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1400000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2000000.0	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1900000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2400000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2500000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	200000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1000000.0	usd
CY2023	us-gaap	Interest Expense InterestExpense	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	0	usd
CY2021	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	100000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2400000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17800000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5700000	usd
CY2023Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	43100000	usd
CY2022Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	35900000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25700000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18700000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2500000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2400000	usd
CY2023Q4	arvn	Accrued General And Administrative And Commercial Current AccruedGeneralAndAdministrativeAndCommercialCurrent	2400000	usd
CY2022Q4	arvn	Accrued General And Administrative And Commercial Current AccruedGeneralAndAdministrativeAndCommercialCurrent	1700000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	700000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10300000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	92200000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	74700000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	200000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	800000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	usd
CY2018Q2	arvn	Percentage Of Maximum Funding On Project Costs PercentageOfMaximumFundingOnProjectCosts	0.50
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	200000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	arvn	Number Of Votes Per Common Stock Share Held NumberOfVotesPerCommonStockShareHeld	1	vote
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	71600000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	75500000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57100000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	53600000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.99
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	39.17
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	52.85
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1400000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7900000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	46900000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20900000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1700000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	8200000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2600000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12700000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20900000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20900000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.184
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.016
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.163
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.076
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.034
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.027
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2023	arvn	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	-0.002
CY2022	arvn	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0.036
CY2021	arvn	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0.011
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.005
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.012
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.012
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.014
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.027
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.454
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.317
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.384
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.003
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.080
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	151200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	143000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	93600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	56300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	43400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	25900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	43800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	10400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	13300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	411100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	247100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2400000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2600000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	800000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1000000.0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3200000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	407900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	243500000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	arvn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	4900000	usd
CY2022Q4	arvn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	3200000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1800000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4100000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5900000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	400000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1600000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15200000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	7000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-367300000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-282500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191000000.0	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55500000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55500000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53200000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53200000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000.0	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000.0	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.62
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.62
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.82
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.82
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9100000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7300000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5400000	shares

Files In Submission

Name	View Source	Status
0001655759-24-000018-index-headers.html	Edgar Link	pending
0001655759-24-000018-index.html	Edgar Link	pending
0001655759-24-000018.txt	Edgar Link	pending
0001655759-24-000018-xbrl.zip	Edgar Link	pending
arvinas-exchangexcompliant.htm	Edgar Link	pending
arvn-20231231.htm	Edgar Link	pending
arvn-20231231.xsd	Edgar Link	pending
arvn-20231231x10kxex21_1.htm	Edgar Link	pending
arvn-20231231x10kxex311.htm	Edgar Link	pending
arvn-20231231x10kxex312.htm	Edgar Link	pending
arvn-20231231x10kxex321.htm	Edgar Link	pending
arvn-20231231x10kxex322.htm	Edgar Link	pending
arvn-20231231_g1.jpg	Edgar Link	pending
arvn-20231231_g10.jpg	Edgar Link	pending
arvn-20231231_g11.jpg	Edgar Link	pending
arvn-20231231_g12.jpg	Edgar Link	pending
arvn-20231231_g2.jpg	Edgar Link	pending
arvn-20231231_g3.jpg	Edgar Link	pending
arvn-20231231_g4.jpg	Edgar Link	pending
arvn-20231231_g5.jpg	Edgar Link	pending
arvn-20231231_g6.jpg	Edgar Link	pending
arvn-20231231_g7.jpg	Edgar Link	pending
arvn-20231231_g8.jpg	Edgar Link	pending
arvn-20231231_g9.jpg	Edgar Link	pending
consent-form10kfy23.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
arvn-20231231_lab.xml	Edgar Link	unprocessable
arvn-20231231_pre.xml	Edgar Link	unprocessable
arvn-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
arvn-20231231_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
arvn-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARVN
Arvinas Inc Stock $arvn

2024 Q1 Form 10-K Financial Statement

#000165575924000018 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN Arvinas Inc Stock $arvn

2024 Q1 Form 10-K Financial Statement

#000165575924000018 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN
Arvinas Inc Stock $arvn